Sign in to continue:

Wednesday, March 4th, 2026

Beijing Luzhu Biotechnology Announces Board Meeting to Approve 2025 Annual Results and Final Dividend

Key Points for Investors

  • Date of Board Meeting: March 18, 2026. This is when major decisions regarding annual performance and dividend payouts will be made.
  • Annual Results Announcement: The Group’s financial performance for the entire year of 2025 will be reviewed and approved, which could have a direct impact on the company’s stock valuation.
  • Final Dividend Proposal: The Board will consider the declaration of the final dividend. Any dividend announcement can be price-sensitive and may influence the share price, depending on the payout ratio and overall financial health.

Details for Shareholders

The upcoming board meeting is a critical event for shareholders of Beijing Luzhu Biotechnology. Historically, the approval of annual results and the declaration of dividends are closely watched by the market. The confirmation of positive earnings or an attractive dividend payout can act as a catalyst for share price appreciation. Conversely, any indication of weaker-than-expected results or the absence of a dividend may lead to negative sentiment.

Investors should stay alert to the outcome of this meeting, as the results and any dividend declaration are likely to be price-sensitive and could significantly impact the valuation of the company’s shares.

Board Composition

As of the date of the announcement, the Board comprises:

  • Executive Directors: Mr. KONG Jian (Chairman), Ms. PENG Ling, Ms. ZHANG Yanping
  • Non-executive Directors: Mr. MA Biao, Mr. KONG Shuangquan
  • Independent Non-executive Directors: Ms. HOU Aijun, Mr. LEUNG Wai Yip, Mr. LIANG Yeshi

This diverse Board is responsible for overseeing the Group’s strategic direction and ensuring robust corporate governance.

What to Watch For

  • Investors should monitor the outcome of the March 18, 2026 meeting closely, as both the annual financial results and any dividend announcement are likely to be price-sensitive. These factors could drive significant movement in Beijing Luzhu Biotechnology’s share price.
  • Any deviation from expectations—either positive or negative—regarding earnings or dividends could influence market sentiment and trading activity.

Disclaimer: This article is prepared for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult with licensed financial advisors before making investment decisions. The company’s announcements and financial performance are subject to change and may impact share prices.

View LUZHU BIOTECH-B Historical chart here



Minieye Technology Enters Strategic Partnership for 3,000 Driverless Logistics Vehicles with Ground Iron and Gecko Technology 1234

Minieye Technology Co., Ltd: Strategic Cooperation Agreement in Driverless Logistics Sector Minieye Technology Co., Ltd Announces Strategic Partnership for 3,000 Driverless Logistics Vehicles Key Points for Investors Minieye Technology Co., Ltd has entered into...

SSY Group Limited Announces Approval of Medical Recombinant Collagen Gynecological Gel and BNP Test Kit in China 1

SSY Group Limited Receives Regulatory Approval for Two Key Medical Products SSY Group Limited Announces Regulatory Milestone for New Medical Products Key Highlights SSY Group Limited has successfully obtained medical device registration certificates from...

Legend Holdings Corporation Issues Profit Alert: Expects Over RMB900 Million Net Profit for 2025, Significant Increase from 2024 1

Legend Holdings Issues Significant Profit Alert for FY2025 Legend Holdings Corporation Issues Substantial Profit Alert for FY2025 Key Highlights Expected Net Profit Surge: Legend Holdings Corporation anticipates a net profit attributable to equity holders...

   Ad